Tami Horovitz, Ph.D

Regulatory Project Manager

Dr. Tami Horovitz holds a Ph.D in protein biochemistry supervised by Prof. A.R. Fersht of the University of Cambridge and post-doctoral experience from the Weizmann Institute. She was research assistant in the chemistry department of Imperial College, London. Tami also has a BSc in molecular biology from the University of Edinburgh.

Tami has over 18 years of experience in different aspects of pharmaceutical development, and prior to that she spent 12 years as a research scientist. She managed D-Pharm’s out-sourced non-clinical and preclinical studies, as well as NCE manufacture for clinical studies. In addition to supporting regulatory submissions, Tami has experience in IP management, as well as forging and maintaining corporate partnerships and academic collaborations.

Since joining Gsap, Tami has supported medical device, pharma and cell therapy companies in preparation and planning for regulatory submissions including: CMC and IMPD; preIND and IND; 510k and CE mark submissions; literature searches; clinical evaluations; biological safety and other regulatory required evaluations; as well as biological and clinical risk assessments.

During her work in Gsap, Tami participated in projects for the following companies: Amorphical, Omnix, TPcera, Ivory Graft, Implant B, Sheba Medical Center, N2B, and Nurami Medica, Ophtimed, Lyra Medical, Syqe, CTG Pharma, Eximore, Exostem, Minovia, AvroBio, Lonza and Zion Medical.

Creativity is a natural extension of our enthusiasm
Earl Nightingale